Psychiatric News (7/20) reports, “Disruptions in healthcare services during the COVID-19 pandemic did not significantly reduce the ability of adults to remain in treatment for opioid use disorder (OUD),” investigators concluded in a study that “analyzed deidentified administrative insurance claims for adults aged 18 or older who were covered by commercial insurance or Medicare Advantage from March 2018 to February 2022.” The findings of the 13,113-adult study were published online July 18 in Psychiatric Services, a publication of the American Psychiatric Association.
Related Links:
— “Study Suggests Few Disruptions in Treatment for OUD During the Pandemic, Psychiatric News, July 20, 2023